PDSB
PDS Biotechnology Corp
NASDAQ: PDSB · HEALTHCARE · BIOTECHNOLOGY
$0.97
+1.32% today
Updated 2026-04-30
Market cap
$60.28M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
PDS Biotechnology Corp (PDSB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $163756.00 | $8.73M | $17.05M | $134.09M | $110.91M | $92.62M | $36.22M | $14.49M | $30.89M | $67.20M | $77.01M | $59.39M | $45.36M |
| Cash & equivalents | $140933.00 | $7.86M | $13.73M | $130.19M | $106.40M | $88.07M | $34.65M | $12.16M | $28.84M | $65.24M | $73.82M | $56.56M | $41.69M |
| Current assets | $147394.00 | $8.53M | $15.44M | $131.27M | $107.35M | $89.05M | $35.65M | $14.47M | $30.34M | $66.84M | $76.48M | $59.06M | $45.05M |
| Total liabilities | $3.55M | $24.08M | $44.88M | $11.62M | $21.64M | $30.25M | $6.38M | $2.79M | $3.76M | $3.99M | $33.01M | $33.26M | $26.35M |
| Current liabilities | $3.52M | $1.79M | $3.89M | $8.59M | $6.68M | $12.87M | $6.38M | $2.79M | $3.27M | $3.76M | $9.82M | $13.63M | $17.09M |
| Long-term debt | — | — | — | $3.03M | $14.95M | $17.38M | $30000.00 | — | — | — | $23.02M | $19.51M | $9.20M |
| Shareholder equity | $-3.38M | $-15.35M | $-27.83M | $122.48M | $89.28M | $62.37M | $29.84M | $11.70M | $27.13M | $63.21M | $44.00M | $26.13M | $19.00M |
| Retained earnings | $-8.08M | $-16.04M | $-29.82M | $-62.25M | $-101.07M | $-151.95M | $-192.82M | $-28.94M | $-43.79M | $-60.70M | $-101.56M | $-144.50M | $-182.11M |
| Accounts receivable | — | $459018.00 | — | — | $13493.00 | $3901.00 | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — |